News
Cigna Group shares rise as Q2 results top estimates
Investing.com -- The Cigna (NYSE: CI) Group reported better-than-expected second quarter 2025 results on Wednesday, as strong growth in its Evernorth Health Services segment drove revenue significantly higher. Shares rose 1% following the announcement.
Stocks in a Bloodbath. The Cigna Group (NYSE:CI) is one of the worst-performing stocks on Thursday. The Cigna Group declined by 10.23 percent on Thursday to close at $267.38 apiece as investor ...
Shares of Cigna Group CI tumbled 10.23% to $267.38 Thursday, on what proved to be an all-around grim trading session for the ...
Cigna Group (CI) reported their Q2 and H1 2025 earnings, highlighting significant growth in both sales and revenue year-over-year, although Q2 net income saw a slight dip. Over the past week, Cigna's ...
Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management ...
Cigna Group reaffirmed its 2025 guidance Thursday on the back of solid growth within its Evernorth businesses and limited ...
The Cigna Group (CI) reports robust financial performance with $67.2 billion in revenue, while navigating elevated medical ...
The health insurer issued a decent second-quarter financial report that came in slightly ahead of consensus estimates.
Cigna posts $67.13B Q1 revenue and $7.20 EPS, lifted by Evernorth's 17% growth as healthcare unit faces impact from HCSC deal and rising medical costs.
Revenue from Cigna's pharmacy benefit management business rose 17% to $57.83 billion during the 2nd quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback